Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study
- PMID: 22943186
- PMCID: PMC3488497
- DOI: 10.1186/1750-1172-7-62
Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study
Abstract
Objective: To identify clinical characteristics associated with internal neurofibromas in children with NF1, as a means of ensuring the early identification of patients at high risk for malignant peripheral nerve-sheath tumors developed from preexisting internal neurofibromas.
Patients and methods: We used data from two NF1 populations, in France and North America, respectively. The French database comprised 1083 patients meeting NIH diagnostic criteria for NF1 and the Neurofibromatosis Institute Database of North America comprised 703 patients. Patients younger than 17 years of age were eligible for our study if they had been evaluated for internal neurofibromas using computed tomography and/or magnetic resonance imaging. Clinical characteristics associated with internal neurofibromas by univariate analysis (P ≤ 0.15) were entered into a multiple logistic regression model after checking for potential interactions and confounding. Multiple imputation was used for missing values.
Results: Among the 746 children in the two databases, 357 (48%) met our inclusion criteria. Their mean age was 7.7 ± 5.0 years and there were 192 (53.8%) males. Internal neurofibromas were present in 35 (9.8%) patients. Internal neurofibromas developed earlier in females than in males and their prevalence increased during adolescence. Factors independently associated with internal neurofibromas were age (OR = 1.16 [1.07-1.27]), xanthogranulomas (OR = 5.85 [2.18-15.89]) and presence of both subcutaneous and plexiform neurofibromas (OR = 6.80 [1.52-30.44]).
Conclusions: Several easily recognizable clinical characteristics indicate a high risk of internal neurofibromas in children with NF1 and, therefore, a need for very close monitoring.
Figures
Similar articles
-
Association between benign and malignant peripheral nerve sheath tumors in NF1.Neurology. 2005 Jul 26;65(2):205-11. doi: 10.1212/01.wnl.0000168830.79997.13. Neurology. 2005. PMID: 16043787
-
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):353-7. doi: 10.1136/jnnp.68.3.353. J Neurol Neurosurg Psychiatry. 2000. PMID: 10675220 Free PMC article.
-
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.Neuro Oncol. 2008 Aug;10(4):593-8. doi: 10.1215/15228517-2008-011. Epub 2008 Jun 17. Neuro Oncol. 2008. PMID: 18559970 Free PMC article.
-
[Neurinomas-neurofibromas].Neurochirurgie. 1997;43(1):35-8. Neurochirurgie. 1997. PMID: 9205625 Review. French.
-
Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.Brain Dev. 2006 Jun;28(5):275-80. doi: 10.1016/j.braindev.2005.10.001. Epub 2006 Feb 14. Brain Dev. 2006. PMID: 16481142 Review.
Cited by
-
Predictive Modeling for Clinical Features Associated With Neurofibromatosis Type 1.Neurol Clin Pract. 2021 Dec;11(6):497-505. doi: 10.1212/CPJ.0000000000001089. Neurol Clin Pract. 2021. PMID: 34987881 Free PMC article.
-
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.Orphanet J Rare Dis. 2020 Feb 3;15(1):37. doi: 10.1186/s13023-020-1310-3. Orphanet J Rare Dis. 2020. PMID: 32014052 Free PMC article.
-
Emerging genotype-phenotype relationships in patients with large NF1 deletions.Hum Genet. 2017 Apr;136(4):349-376. doi: 10.1007/s00439-017-1766-y. Epub 2017 Feb 17. Hum Genet. 2017. PMID: 28213670 Free PMC article. Review.
-
A Translational Approach to Spinal Neurofibromatosis: Clinical and Molecular Insights from a Wide Italian Cohort.Cancers (Basel). 2022 Dec 22;15(1):59. doi: 10.3390/cancers15010059. Cancers (Basel). 2022. PMID: 36612057 Free PMC article.
References
-
- Riccardi VM. Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press; 1992.
-
- Tucker T, Riccardi VM, Brown C, Fee J, Sutcliffe M, Vielkind J. et al.S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas. J Neurosci Res. 2011;89(9):1451–1460. doi: 10.1002/jnr.22654. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous